Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3200)
All Articles published online
|
Apr 28, 2005 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tien LT, Ito M, Nakao M, Niino D, Serik M, Nakashima M, Wen CY, Yatsuhashi H, Ishibashi H. Expression of β-catenin in hepatocellular carcinoma. World J Gastroenterol 2005; 11(16): 2398-2401 [PMID: 15832407 DOI: 10.3748/wjg.v11.i16.2398] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i16/2398.htm |
| Number | Citing Articles |
| 1 |
Jenifer R. Prosperi, Hue H. Luu, Kathleen H. Goss. Targeting the Wnt Pathway in Cancer. 2011; : 81 doi: 10.1007/978-1-4419-8023-6_5
|
| 2 |
Matthias Vonbrüll, Elisabeth Riegel, Christian Halter, Michaela Aigner, Holger Bock, Birgit Werner, Thomas Lindhorst, Thomas Czerny. A Dominant Negative Antisense Approach Targeting β-Catenin. Molecular Biotechnology 2018; 60(5): 339 doi: 10.1007/s12033-018-0058-7
|
| 3 |
Michael A. Nalesnik, Tong Wu, Eizaburo Sasatomi, Anthony J. Demetris. Hepatocellular Carcinoma. 2009; : 183 doi: 10.1007/978-1-60327-376-3_6
|
| 4 |
Bin-bin Zhao, Zhi-hua Ye, Xiang Gao, Han-min Li. Diwu Yanggan Modulates the Wnt/β-catenin Pathway and Inhibits Liver Carcinogenesis Signaling in 2-AAF/PH Model Rats. Current Medical Science 2019; 39(6): 913 doi: 10.1007/s11596-019-2123-2
|
| 5 |
Ning Li, Jinhua Jiang, Jing Fu, Ting Yu, Bibo Wang, Wenhao Qin, An Xu, Mengchao Wu, Yao Chen, Hongyang Wang. Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0413-0
|
| 6 |
Basma Awad, Alaaeldin Ahmed Hamza, Amna Al-Maktoum, Suhail Al-Salam, Amr Amin. Combining Crocin and Sorafenib Improves Their Tumor-Inhibiting Effects in a Rat Model of Diethylnitrosamine-Induced Cirrhotic-Hepatocellular Carcinoma. Cancers 2023; 15(16): 4063 doi: 10.3390/cancers15164063
|
| 7 |
KUN-SONG ZHANG, QI ZHOU, YA-FENG WANG, LI-JIAN LIANG. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells. Oncology Reports 2013; 30(3): 1430 doi: 10.3892/or.2013.2560
|
| 8 |
Mohammad Heiat, Hamid Hashemi Yeganeh, Seyed Moayed Alavian, Ehsan Rezaie. Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect. Toxins 2021; 13(10): 719 doi: 10.3390/toxins13100719
|
| 9 |
Abeer Bahnassy, Azza M. Gawish, Abeer Mostafa, El-Shaimaa Refaat, Gamal Esmat. Role of Wnt/β-catenin pathway genes in the development and progression of hepatitis C virus-associated hepatocellular carcinoma. Egyptian Journal of Pathology 2012; 32(1): 99 doi: 10.1097/01.XEJ.0000417557.16381.38
|
| 10 |
YANG YANG, MENGHE LI, SU’E CHANG, LUMIN WANG, TUSHENG SONG, LING GAO, LILI HU, ZONGFANG LI, LIYING LIU, JIAYI YAO, CHEN HUANG. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells. Molecular Medicine Reports 2014; 10(5): 2643 doi: 10.3892/mmr.2014.2526
|
| 11 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_166-1
|
| 12 |
Hongzhi Zhao, Liang Zhao, Lin Wu, Sheng Hu, Yangmei Huang, Wei Zhao. Hydrogen sulfide suppresses H2O2-induced proliferation and migration of HepG2 cells through Wnt/β-catenin signaling pathway. Medical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02091-w
|
| 13 |
Xufeng Zhang, Liang Yu, Yi Lu. Wnt/β-catenin signaling pathway and its role in hepatocellular carcinoma. Frontiers of Medicine in China 2008; 2(3): 216 doi: 10.1007/s11684-008-0042-x
|
| 14 |
Susumu Matsukuma, Kimiya Sato. Peritoneal seeding of hepatocellular carcinoma: Clinicopathological characteristics of 17 autopsy cases. Pathology International 2011; 61(6): 356 doi: 10.1111/j.1440-1827.2011.02669.x
|
| 15 |
Wendy J. van Zuylen, William D. Rawlinson, Caroline E. Ford. The Wnt pathway: a key network in cell signalling dysregulated by viruses. Reviews in Medical Virology 2016; 26(5): 340 doi: 10.1002/rmv.1892
|
| 16 |
Jian-Ji Li, Zhe Yang, Zan-Song Huang. Progress in basic and clinical research on molecular targeted therapy for primary hepatic carcinoma. World Chinese Journal of Digestology 2019; 27(10): 643 doi: 10.11569/wcjd.v27.i10.643
|
| 17 |
Hai-Yang Xie, Jun Cheng, Chun-Yang Xing, Jin-Jin Wang, Rong Su, Xu-Yong Wei, Lin Zhou, Shu-Sen Zheng. Evaluation of hepatitis B viral replication and proteomic analysis of HepG2.2.15 cell line after knockdown of HBx. Hepatobiliary & Pancreatic Diseases International 2011; 10(3): 295 doi: 10.1016/S1499-3872(11)60049-0
|
| 18 |
Gudrun Zulehner, Mario Mikula, Doris Schneller, Franziska van Zijl, Heidemarie Huber, Wolfgang Sieghart, Bettina Grasl-Kraupp, Thomas Waldhör, Markus Peck-Radosavljevic, Hartmut Beug, Wolfgang Mikulits. Nuclear β-Catenin Induces an Early Liver Progenitor Phenotype in Hepatocellular Carcinoma and Promotes Tumor Recurrence. The American Journal of Pathology 2010; 176(1): 472 doi: 10.2353/ajpath.2010.090300
|
| 19 |
Wei Liu, Xiaochun Liang, Dan Yang. The Effects of Chinese Medicine on Activation of Wnt/β-Catenin Signal Pathway under High Glucose Condition. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/295135
|
| 20 |
Iris Suarez M., Diego Uribe, Carlos M. Jaramillo, German Osorio, Juan C. Perez, Rocio Lopez, Sergio Hoyos, Pierre Hainaut, Pascal Pineau, Maria-C. Navas. Wnt/β-catenin signaling pathway in hepatocellular carcinomas cases from Colombia. Annals of Hepatology 2015; 14(1): 64 doi: 10.1016/S1665-2681(19)30802-6
|
| 21 |
Chang Wook Kim, Seung Kew Yoon, Eun Sun Jung, Chan Kwon Jung, Jeong Won Jang, Min Soo Kim, So Yeon Lee, Si Hyun Bae, Jong Young Choi, Sang Wook Choi, Nam Ik Han, Chang Don Lee. Correlation of hepatitis B core antigen and β‐catenin expression on hepatocytes in chronic hepatitis B virus infection: Relevance to the severity of liver damage and viral replication. Journal of Gastroenterology and Hepatology 2007; 22(9): 1534 doi: 10.1111/j.1440-1746.2007.04849.x
|
| 22 |
Reem Mebed , Yasser BM Ali, Nahla Shehata, Nahla Gamal, Nadia El-Guendy, Abdel-Rahman Zekri, Salwa Sabet. Combining Bevacizumab with Knocked-Down β-Catenin Reduces
VEGF-A and Slug mRNA in HepG2 but not in Caco-2 Cell Lines. Current Molecular Medicine 2022; 22(4): 374 doi: 10.2174/1573405617666210824120618
|
| 23 |
Qi-Ming Wang, Ye Zhang, Kai-Ming Yang, Hong-Ying Zhou, Hui-Jun Yang. Wnt/β-catenin signaling pathway is active in pancreatic development of rat embryo. World Journal of Gastroenterology 2006; 12(16): 2615-2619 doi: 10.3748/wjg.v12.i16.2615
|
| 24 |
Hiroyasu Sakai, Yasuhiro Yamada, Masaya Kubota, Kenji Imai, Yohei Shirakami, Hiroyuki Tomita, Akira Hara, Masahito Shimizu. The phosphorylated retinoid X receptor-α promotes diethylnitrosamine-induced hepatocarcinogenesis in mice through the activation of β-catenin signaling pathway. Carcinogenesis 2022; 43(3): 254 doi: 10.1093/carcin/bgab099
|
| 25 |
Heun-Sik Lee, Dong Chul Lee, Mee-Hee Park, Suk-Jin Yang, Jung Ju Lee, Dong Min Kim, Yejin Jang, Jae-Hyuck Lee, Jong Young Choi, Yun Kyung Kang, Dae Il Kim, Kyung Chan Park, Seon-Young Kim, Hyang-Sook Yoo, Eui-Ju Choi, Young Il Yeom. STMN2 is a novel target of β-catenin/TCF-mediated transcription in human hepatoma cells. Biochemical and Biophysical Research Communications 2006; 345(3): 1059 doi: 10.1016/j.bbrc.2006.05.017
|
| 26 |
Jiang Chen, Jinghua Liu, Renan Jin, Jiliang Shen, Yuelong Liang, Rui Ma, Hui Lin, Xiao Liang, Hong Yu, Xiujun Cai, Andreas Krieg. Cytoplasmic and/or Nuclear Expression of β-Catenin Correlate with Poor Prognosis and Unfavorable Clinicopathological Factors in Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE 2014; 9(11): e111885 doi: 10.1371/journal.pone.0111885
|
| 27 |
Alampady K. Shanbhogue, Srinivasa R. Prasad, Naoki Takahashi, Raghunandan Vikram, Dushyant V. Sahani. Recent Advances in Cytogenetics and Molecular Biology of Adult Hepatocellular Tumors: Implications for Imaging and Management. Radiology 2011; 258(3): 673 doi: 10.1148/radiol.10100376
|
| 28 |
Shaikh Maryam Ghufran, Sachin Sharma, Sampa Ghose, Subhrajit Biswas. Context dependent role of p53 during the interaction of hepatocellular carcinoma and endothelial cells. Microvascular Research 2022; 142: 104374 doi: 10.1016/j.mvr.2022.104374
|
| 29 |
Nur Rahadiani, Ignasia Andhini Retnowulan, Marini Stephanie, Diah Rini Handjari, Ening Krisnuhoni. β-Catenin Expression and Its Association with Prognostic Factors in Hepatocellular Carcinoma: A Study on Alpha-fetoprotein, Histologic Grade, and Microvascular Invasion. Open Access Macedonian Journal of Medical Sciences 2021; 9(A): 887 doi: 10.3889/oamjms.2021.6123
|
| 30 |
Heun-Sik Lee, Mee-Hee Park, Suk-Jin Yang, Kyung Chan Park, Nam-Soon Kim, Yong-Sung Kim, Dae Il Kim, Hyang-Sook Yoo, Eui-Ju Choi, Young Il Yeom. Novel candidate targets of Wnt/β-catenin signaling in hepatoma cells. Life Sciences 2007; 80(7): 690 doi: 10.1016/j.lfs.2006.10.024
|
| 31 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2987 doi: 10.1007/978-3-319-26956-6_166
|
| 32 |
Scott V. Perryman, Karl G. Sylvester. Repair and regeneration: opportunities for carcinogenesis from tissue stem cells. Journal of Cellular and Molecular Medicine 2006; 10(2): 292 doi: 10.1111/j.1582-4934.2006.tb00400.x
|
| 33 |
F. Farinati, R. Cardin, M. Bortolami, P. Burra, F. P. Russo, M. Rugge, M. Guido, A. Sergio, R. Naccarato. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. Journal of Viral Hepatitis 2007; 14(12): 821 doi: 10.1111/j.1365-2893.2007.00878.x
|
| 34 |
Julum Nwanze, Cynthia Cohen, Alessandra C. Schmitt, Momin T. Siddiqui. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization. Acta Cytologica 2015; 59(6): 479 doi: 10.1159/000443602
|
| 35 |
Mohan Krishna Ghanta, Mohammad Faiz Hussain, Asmita Karnalkar, Sirpu Natesh Nagabhishek, Poojith Nuthalapati, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 401 doi: 10.1016/B978-0-323-99283-1.00003-3
|
| 36 |
Yuanyuan Feng, Xinfang Tang, Changcheng Li, Ying Su, Xiaoyu Wang, Ning Li, Anna Zhang, Feng Jiang, Chuyan Wu, Antonio Giovanni Solimando. ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/3163955
|
| 37 |
Young‐Dae Kim, Chang‐Hwan Park, Hyun‐Soo Kim, Sung‐Kyu Choi, Jong‐Sun Rew, Dong‐Yi Kim, Yang‐Suk Koh, Kyung‐Woon Jeung, Kyung‐Hwa Lee, Ji‐Shin Lee, Sang‐Woo Juhng, Jae‐Hyuk Lee. Genetic alterations of Wnt signaling pathway–associated genes in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2008; 23(1): 110 doi: 10.1111/j.1440-1746.2007.05250.x
|
| 38 |
Jinn-Rung Kuo, Hung-Sheng Shang, Chun-Te Ho, Kun-Goung Lai, Tsan-Zon Liu, Yin-Ju Chen, Jeng-Fong Chiou. Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting. Oncology Letters 2016; 12(5): 3723 doi: 10.3892/ol.2016.5181
|